Copyright Reports & Markets. All rights reserved.

Global Precision Medicine Market 2025 by Company, Regions, Type and Application, Forecast to 2031

Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Precision Medicine by Type
    • 1.3.1 Overview: Global Precision Medicine Market Size by Type: 2020 Versus 2024 Versus 2031
    • 1.3.2 Global Precision Medicine Consumption Value Market Share by Type in 2024
    • 1.3.3 Diagnostics
    • 1.3.4 Therapies
  • 1.4 Global Precision Medicine Market by Application
    • 1.4.1 Overview: Global Precision Medicine Market Size by Application: 2020 Versus 2024 Versus 2031
    • 1.4.2 Oncology
    • 1.4.3 Neurosciences
    • 1.4.4 Immunology
    • 1.4.5 Respiratory
    • 1.4.6 Others
  • 1.5 Global Precision Medicine Market Size & Forecast
  • 1.6 Global Precision Medicine Market Size and Forecast by Region
    • 1.6.1 Global Precision Medicine Market Size by Region: 2020 VS 2024 VS 2031
    • 1.6.2 Global Precision Medicine Market Size by Region, (2020-2031)
    • 1.6.3 North America Precision Medicine Market Size and Prospect (2020-2031)
    • 1.6.4 Europe Precision Medicine Market Size and Prospect (2020-2031)
    • 1.6.5 Asia-Pacific Precision Medicine Market Size and Prospect (2020-2031)
    • 1.6.6 South America Precision Medicine Market Size and Prospect (2020-2031)
    • 1.6.7 Middle East & Africa Precision Medicine Market Size and Prospect (2020-2031)

2 Company Profiles

  • 2.1 Johnson & Johnson
    • 2.1.1 Johnson & Johnson Details
    • 2.1.2 Johnson & Johnson Major Business
    • 2.1.3 Johnson & Johnson Precision Medicine Product and Solutions
    • 2.1.4 Johnson & Johnson Precision Medicine Revenue, Gross Margin and Market Share (2020-2025)
    • 2.1.5 Johnson & Johnson Recent Developments and Future Plans
  • 2.2 Roche
    • 2.2.1 Roche Details
    • 2.2.2 Roche Major Business
    • 2.2.3 Roche Precision Medicine Product and Solutions
    • 2.2.4 Roche Precision Medicine Revenue, Gross Margin and Market Share (2020-2025)
    • 2.2.5 Roche Recent Developments and Future Plans
  • 2.3 Labcorp
    • 2.3.1 Labcorp Details
    • 2.3.2 Labcorp Major Business
    • 2.3.3 Labcorp Precision Medicine Product and Solutions
    • 2.3.4 Labcorp Precision Medicine Revenue, Gross Margin and Market Share (2020-2025)
    • 2.3.5 Labcorp Recent Developments and Future Plans
  • 2.4 Abbott Laboratories
    • 2.4.1 Abbott Laboratories Details
    • 2.4.2 Abbott Laboratories Major Business
    • 2.4.3 Abbott Laboratories Precision Medicine Product and Solutions
    • 2.4.4 Abbott Laboratories Precision Medicine Revenue, Gross Margin and Market Share (2020-2025)
    • 2.4.5 Abbott Laboratories Recent Developments and Future Plans
  • 2.5 Novartis
    • 2.5.1 Novartis Details
    • 2.5.2 Novartis Major Business
    • 2.5.3 Novartis Precision Medicine Product and Solutions
    • 2.5.4 Novartis Precision Medicine Revenue, Gross Margin and Market Share (2020-2025)
    • 2.5.5 Novartis Recent Developments and Future Plans
  • 2.6 Illumina
    • 2.6.1 Illumina Details
    • 2.6.2 Illumina Major Business
    • 2.6.3 Illumina Precision Medicine Product and Solutions
    • 2.6.4 Illumina Precision Medicine Revenue, Gross Margin and Market Share (2020-2025)
    • 2.6.5 Illumina Recent Developments and Future Plans
  • 2.7 GE Healthcare
    • 2.7.1 GE Healthcare Details
    • 2.7.2 GE Healthcare Major Business
    • 2.7.3 GE Healthcare Precision Medicine Product and Solutions
    • 2.7.4 GE Healthcare Precision Medicine Revenue, Gross Margin and Market Share (2020-2025)
    • 2.7.5 GE Healthcare Recent Developments and Future Plans
  • 2.8 Intel Corporation
    • 2.8.1 Intel Corporation Details
    • 2.8.2 Intel Corporation Major Business
    • 2.8.3 Intel Corporation Precision Medicine Product and Solutions
    • 2.8.4 Intel Corporation Precision Medicine Revenue, Gross Margin and Market Share (2020-2025)
    • 2.8.5 Intel Corporation Recent Developments and Future Plans
  • 2.9 Biomrieux Sa
    • 2.9.1 Biomrieux Sa Details
    • 2.9.2 Biomrieux Sa Major Business
    • 2.9.3 Biomrieux Sa Precision Medicine Product and Solutions
    • 2.9.4 Biomrieux Sa Precision Medicine Revenue, Gross Margin and Market Share (2020-2025)
    • 2.9.5 Biomrieux Sa Recent Developments and Future Plans
  • 2.10 Cepheid
    • 2.10.1 Cepheid Details
    • 2.10.2 Cepheid Major Business
    • 2.10.3 Cepheid Precision Medicine Product and Solutions
    • 2.10.4 Cepheid Precision Medicine Revenue, Gross Margin and Market Share (2020-2025)
    • 2.10.5 Cepheid Recent Developments and Future Plans
  • 2.11 IBM
    • 2.11.1 IBM Details
    • 2.11.2 IBM Major Business
    • 2.11.3 IBM Precision Medicine Product and Solutions
    • 2.11.4 IBM Precision Medicine Revenue, Gross Margin and Market Share (2020-2025)
    • 2.11.5 IBM Recent Developments and Future Plans
  • 2.12 Qiagen
    • 2.12.1 Qiagen Details
    • 2.12.2 Qiagen Major Business
    • 2.12.3 Qiagen Precision Medicine Product and Solutions
    • 2.12.4 Qiagen Precision Medicine Revenue, Gross Margin and Market Share (2020-2025)
    • 2.12.5 Qiagen Recent Developments and Future Plans
  • 2.13 Thermo Fisher Scientific
    • 2.13.1 Thermo Fisher Scientific Details
    • 2.13.2 Thermo Fisher Scientific Major Business
    • 2.13.3 Thermo Fisher Scientific Precision Medicine Product and Solutions
    • 2.13.4 Thermo Fisher Scientific Precision Medicine Revenue, Gross Margin and Market Share (2020-2025)
    • 2.13.5 Thermo Fisher Scientific Recent Developments and Future Plans
  • 2.14 Randox Laboratories
    • 2.14.1 Randox Laboratories Details
    • 2.14.2 Randox Laboratories Major Business
    • 2.14.3 Randox Laboratories Precision Medicine Product and Solutions
    • 2.14.4 Randox Laboratories Precision Medicine Revenue, Gross Margin and Market Share (2020-2025)
    • 2.14.5 Randox Laboratories Recent Developments and Future Plans
  • 2.15 Almac Group
    • 2.15.1 Almac Group Details
    • 2.15.2 Almac Group Major Business
    • 2.15.3 Almac Group Precision Medicine Product and Solutions
    • 2.15.4 Almac Group Precision Medicine Revenue, Gross Margin and Market Share (2020-2025)
    • 2.15.5 Almac Group Recent Developments and Future Plans
  • 2.16 Healthcore
    • 2.16.1 Healthcore Details
    • 2.16.2 Healthcore Major Business
    • 2.16.3 Healthcore Precision Medicine Product and Solutions
    • 2.16.4 Healthcore Precision Medicine Revenue, Gross Margin and Market Share (2020-2025)
    • 2.16.5 Healthcore Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Precision Medicine Revenue and Share by Players (2020-2025)
  • 3.2 Market Share Analysis (2024)
    • 3.2.1 Market Share of Precision Medicine by Company Revenue
    • 3.2.2 Top 3 Precision Medicine Players Market Share in 2024
    • 3.2.3 Top 6 Precision Medicine Players Market Share in 2024
  • 3.3 Precision Medicine Market: Overall Company Footprint Analysis
    • 3.3.1 Precision Medicine Market: Region Footprint
    • 3.3.2 Precision Medicine Market: Company Product Type Footprint
    • 3.3.3 Precision Medicine Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Precision Medicine Consumption Value and Market Share by Type (2020-2025)
  • 4.2 Global Precision Medicine Market Forecast by Type (2026-2031)

5 Market Size Segment by Application

  • 5.1 Global Precision Medicine Consumption Value Market Share by Application (2020-2025)
  • 5.2 Global Precision Medicine Market Forecast by Application (2026-2031)

6 North America

  • 6.1 North America Precision Medicine Consumption Value by Type (2020-2031)
  • 6.2 North America Precision Medicine Market Size by Application (2020-2031)
  • 6.3 North America Precision Medicine Market Size by Country
    • 6.3.1 North America Precision Medicine Consumption Value by Country (2020-2031)
    • 6.3.2 United States Precision Medicine Market Size and Forecast (2020-2031)
    • 6.3.3 Canada Precision Medicine Market Size and Forecast (2020-2031)
    • 6.3.4 Mexico Precision Medicine Market Size and Forecast (2020-2031)

7 Europe

  • 7.1 Europe Precision Medicine Consumption Value by Type (2020-2031)
  • 7.2 Europe Precision Medicine Consumption Value by Application (2020-2031)
  • 7.3 Europe Precision Medicine Market Size by Country
    • 7.3.1 Europe Precision Medicine Consumption Value by Country (2020-2031)
    • 7.3.2 Germany Precision Medicine Market Size and Forecast (2020-2031)
    • 7.3.3 France Precision Medicine Market Size and Forecast (2020-2031)
    • 7.3.4 United Kingdom Precision Medicine Market Size and Forecast (2020-2031)
    • 7.3.5 Russia Precision Medicine Market Size and Forecast (2020-2031)
    • 7.3.6 Italy Precision Medicine Market Size and Forecast (2020-2031)

8 Asia-Pacific

  • 8.1 Asia-Pacific Precision Medicine Consumption Value by Type (2020-2031)
  • 8.2 Asia-Pacific Precision Medicine Consumption Value by Application (2020-2031)
  • 8.3 Asia-Pacific Precision Medicine Market Size by Region
    • 8.3.1 Asia-Pacific Precision Medicine Consumption Value by Region (2020-2031)
    • 8.3.2 China Precision Medicine Market Size and Forecast (2020-2031)
    • 8.3.3 Japan Precision Medicine Market Size and Forecast (2020-2031)
    • 8.3.4 South Korea Precision Medicine Market Size and Forecast (2020-2031)
    • 8.3.5 India Precision Medicine Market Size and Forecast (2020-2031)
    • 8.3.6 Southeast Asia Precision Medicine Market Size and Forecast (2020-2031)
    • 8.3.7 Australia Precision Medicine Market Size and Forecast (2020-2031)

9 South America

  • 9.1 South America Precision Medicine Consumption Value by Type (2020-2031)
  • 9.2 South America Precision Medicine Consumption Value by Application (2020-2031)
  • 9.3 South America Precision Medicine Market Size by Country
    • 9.3.1 South America Precision Medicine Consumption Value by Country (2020-2031)
    • 9.3.2 Brazil Precision Medicine Market Size and Forecast (2020-2031)
    • 9.3.3 Argentina Precision Medicine Market Size and Forecast (2020-2031)

10 Middle East & Africa

  • 10.1 Middle East & Africa Precision Medicine Consumption Value by Type (2020-2031)
  • 10.2 Middle East & Africa Precision Medicine Consumption Value by Application (2020-2031)
  • 10.3 Middle East & Africa Precision Medicine Market Size by Country
    • 10.3.1 Middle East & Africa Precision Medicine Consumption Value by Country (2020-2031)
    • 10.3.2 Turkey Precision Medicine Market Size and Forecast (2020-2031)
    • 10.3.3 Saudi Arabia Precision Medicine Market Size and Forecast (2020-2031)
    • 10.3.4 UAE Precision Medicine Market Size and Forecast (2020-2031)

11 Market Dynamics

  • 11.1 Precision Medicine Market Drivers
  • 11.2 Precision Medicine Market Restraints
  • 11.3 Precision Medicine Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 Precision Medicine Industry Chain
  • 12.2 Precision Medicine Upstream Analysis
  • 12.3 Precision Medicine Midstream Analysis
  • 12.4 Precision Medicine Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Precision Medicine market size was valued at US$ 146930 million in 2024 and is forecast to a readjusted size of USD 273270 million by 2031 with a CAGR of 9.4% during review period.
    According to the National Institutes of Health (NIH), precision medicine is "an emerging approach for disease treatment and prevention that takes into account individual variability in genes, environment, and lifestyle for each person." This approach will allow doctors and researchers to predict more accurately which treatment and prevention strategies for a particular disease will work in which groups of people. It is in contrast to a "one-size-fits-all" approach, in which disease treatment and prevention strategies are developed for the average person, with less consideration for the differences between individuals.
    Although the term "precision medicine" is relatively new, the concept has been a part of healthcare for many years. For example, a person who needs a blood transfusion is not given blood from a randomly selected donor; instead, the donor’s blood type is matched to the recipient to reduce the risk of complications. Although examples can be found in several areas of medicine, the role of precision medicine in day-to-day healthcare is relatively limited. Researchers hope that this approach will expand to many areas of health in coming years.
    The classification of precision medicine includes diagnostics and therapies, and the proportion of diagnostics is about 67%.
    Precision Medicine is used for oncology, neurosciences, immunology, respiratory and other field. The most proportion of precision medicine is for oncology, and the market share is about 30%.
    Market competition is intense. Johnson & Johnson, Roche, Labcorp, Abbott Laboratories and Novartis are the leaders of the industry, with about 56% market shares.
    This report is a detailed and comprehensive analysis for global Precision Medicine market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Precision Medicine market size and forecasts, in consumption value ($ Million), 2020-2031
    Global Precision Medicine market size and forecasts by region and country, in consumption value ($ Million), 2020-2031
    Global Precision Medicine market size and forecasts, by Type and by Application, in consumption value ($ Million), 2020-2031
    Global Precision Medicine market shares of main players, in revenue ($ Million), 2020-2025
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Precision Medicine
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Precision Medicine market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Johnson & Johnson, Roche, Labcorp, Abbott Laboratories, Novartis, Illumina, GE Healthcare, Intel Corporation, Biomrieux Sa, Cepheid, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market segmentation
    Precision Medicine market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Diagnostics
    Therapies
    Market segment by Application
    Oncology
    Neurosciences
    Immunology
    Respiratory
    Others
    Market segment by players, this report covers
    Johnson & Johnson
    Roche
    Labcorp
    Abbott Laboratories
    Novartis
    Illumina
    GE Healthcare
    Intel Corporation
    Biomrieux Sa
    Cepheid
    IBM
    Qiagen
    Thermo Fisher Scientific
    Randox Laboratories
    Almac Group
    Healthcore
    Market segment by regions, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
    South America (Brazil, Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 13 chapters:
    Chapter 1, to describe Precision Medicine product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top players of Precision Medicine, with revenue, gross margin, and global market share of Precision Medicine from 2020 to 2025.
    Chapter 3, the Precision Medicine competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
    Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2020 to 2031
    Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2020 to 2025.and Precision Medicine market forecast, by regions, by Type and by Application, with consumption value, from 2026 to 2031.
    Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
    Chapter 12, the key raw materials and key suppliers, and industry chain of Precision Medicine.
    Chapter 13, to describe Precision Medicine research findings and conclusion.

    Buy now